|
Market Cap (5-Jun) $111,926,056 (1,449th) |
Close (30-Jun) $0.075 |
Volume (30-Jun) 0 |
Shortsold (11-Oct) 108,089 (0.02%) (492nd) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.02 |
PAA released this announcement to the ASX on 30 June 2023, 9:48. The announcement is marked as price sensitive, and is 2 page(s) in length and 217.47kb in size.
You can view all announcements from PAA and see how they appear on a price chart on the announcements page.
At the date of this announcement, PAA was 0.001% short sold according to ASIC data. It was ranked the 637th most shorted stock on the ASX. It is now ranked as the 492nd most shorted stock on the ASX with 0.022% of total shares short sold as of the latest reported data (11 October 2024).
| Other Recent Announcements from PAA | |
|---|---|
| Results of General Meeting | 30 June 2023, 12:38 |
| Trading Halt | 30 June 2023, 9:48 |
| General Meeting - Chairman Script | 30 June 2023, 9:42 |
| Motor Neurone Disease Phase 1/2 Clinical Trial Update | 27 June 2023, 8:17 |
| Commencement of Cohort 3 in Phase 1/2 MND Trial | 9 June 2023, 9:54 |
You must be logged in to post a reply.
PharmAust 